230 results on '"Rudà, Roberta"'
Search Results
2. Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study
3. Health professional involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma
4. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
5. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
6. Epilepsy in gliomas: recent insights into risk factors and molecular pathways
7. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
8. Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
9. Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience
10. Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.
11. Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)
12. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
13. Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
14. Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology)
15. IDH inhibition in gliomas: from preclinical models to clinical trials.
16. Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.
17. Prevention of Brain Metastases: A New Frontier.
18. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
19. Medulloblastoma in adults: an analysis of clinico-pathological, molecular and treatment factors.
20. A survey on clinical pathways of patients with epilepsy and cerebrovascular diseases or brain tumors
21. The Impact of Lateral Ventricular Opening in the Resection of Newly Diagnosed High-Grade Gliomas: A Single Center Experience.
22. Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative.
23. Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016
24. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
25. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
26. Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management.
27. The early recognition and diagnosis of neoplastic meningitis.
28. Advances in molecular and imaging biomarkers in lower-grade gliomas.
29. Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment
30. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
31. Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group.
32. Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
33. Linea guida per la terapia dei prolattinomi: Associazione Medici Endocrinologi (AME); Istituto Superiore di Sanità 2022; Associazione Italiana di Neuro-Oncologia (AINO); Associazione Italiana di Neuroradiologia Diagnostica e Interventistica (AINR); Associazione Italiana di Radioterapia e Oncologia Clinica (AIRO); Associazione Nazionale Italiana Patologie Ipofisarie (ANIPI); Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioc); Società Italiana di Endocrinologia (SIE); Società Italiana di Ginecologia e Ostetricia (SIGO); Società Italiana di Neurochirurgia (SINch)
34. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
35. Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study
36. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
37. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe
38. Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
39. Neurotoxicity from Old and New Radiation Treatments for Brain Tumors.
40. Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
41. Spontaneous intracranial hypotension: a case series and literature review.
42. EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.
43. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.
44. Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps
45. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)
46. Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review.
47. Rare Neuronal, Glial and Glioneuronal Tumours in Adults.
48. Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience
49. Pharmacologic Therapies for Malignant Glioma: A Guide for Clinicians
50. MGMT promoter methylation in plasma of glioma patients receiving temozolomide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.